Biocon Biologics
Cedric Ruscio is a seasoned professional in the healthcare and pharmaceutical sectors, currently serving as the Country Manager for Switzerland at Biocon Biologics since November 2023. Ruscio has a robust background in commercial management and sales, previously holding the position of Commercial Manager Oncology Switzerland at iQone Healthcare Group from May 2017 to October 2023. Prior roles include National Sales Manager at Novigenix SA, where responsibilities focused on colorectal cancer prevention diagnostics, and various managerial positions at L'Oréal and Almirall, emphasizing dermatology, pneumology, and gastroenterology. With experience dating back to 1990, Cedric has developed expertise across multiple therapeutic areas and has successfully launched new products and implemented key performance indicators during his tenure at companies such as AstraZeneca and Dansac A/S. Cedric holds a federal diploma in sales management and certifications in English and sales direction from reputable institutions.
This person is not in any teams
This person is not in any offices
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics